FLT4 and neoplasm: Our findings suggest that LN metastasis is dependent on tumour-induced lymphangiogenesis and indicate that the inhibition of lymphangiogenesis targeting VEGFR-3 is a realistic therapeutic strategy for inhibiting LN metastasis.